|
Match
|
Document |
Document Title |
|
|
6809198 |
Sucralose composition and process for its preparation
The present invention provides an improved form of sucralose and a process for making it.
|
|
|
6803459 |
Branched starches and branched starch hydrolyzates
The present invention provides a starch that includes at least one glucose polymer having greater than 4% alpha 1-6 glycosidic linkages. The present invention further provides a starch hydrolyzate...
|
|
|
6800754 |
Method for producing cellulose sulfoacetate derivatives and products and mixtures thereof
A method for directly producing a mixture of cellulose sulfoacetate derivatives by esterification of cellulosic material, characterized in that it comprises the following steps i) the cellulosic...
|
|
|
6800741 |
Alkoxylated surfactants based upon alkyl polyglycoside
The invention relates to a series of polyglycoside derivatives that have improved water-solubility by introducing into the molecule polyoxyalkylene groups like polyoxyethylene and polyoxypropylene....
|
|
|
6780990 |
Hydrogenated starch hydrolysate
A hydrogenated starch hydrolysate having the following saccharide contents (based on the solids content of the hydrogenated starch hydrolysate): A.<8 wt.-% of hydrogenated monosaccharides...
|
|
|
6777398 |
Process for the preparation of chondroitin sulfates from K4 polysaccharide and obtained products
New process for the preparation of chondroitin sulfates from the bacterial origin polysaccharide named K4, by defructosilation followed by selective sulfation.
|
|
|
6770758 |
Polysaccharide separation method
A method for the separation of polysaccharides. The method comprises conjugating a ligand to a thermo-sensitive polymer to form a conjugate, wherein the ligand specifically recognizes a...
|
|
|
6765091 |
Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them
The present invention relates to the field of the Medicine, in particular with the chemical synthesis of oligosaccharide mixtures derived of ribose-ribitol-phosphate, which are used as active...
|
|
|
6765069 |
Plasma cross-linked hydrophilic coating
A method for making a hydrophilic and lubricious coating, the coating so made and a medical device including such coating, wherein the coating includes a hydrophilic polymeric unit layer...
|
|
|
6750332 |
Salicyl alcohol derivatives
Novel salicyl alcohol derivatives having valuable cosmetically and pharmaceutically useful properties, such as prostaglandin synthesis inhibition, corresponding to the formula (I): R 1 —OCH 2...
|
|
|
6750331 |
Oligosaccharide-supplying compositions
The present invention provides an oligosaccharide-supplying composition which contains 10 to 80% by weight of oligosaccharide, 0.3 to 10% by weight of a foaming component and 0.9 to 30% by weight...
|
|
|
6740752 |
Process for preparing chitosan particles
Disclosed is a process for producing particles of the modified carbohydrate polymer chitosan. Such chitosan particles are “activated” as a consequence of the specific steps used in the process....
|
|
|
6734299 |
Treatment for substrates
A water-soluble or water-dispersible material for deposition onto a substrate during a treatment process, the material comprising: (i) a deposition enhancing part having a polymeric backbone; and...
|
|
|
6730661 |
Nutritional composition which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
The present invention relates to the use of one or more non-digestible polysaccharides selected from the group consisting of dextrans having a molecular weight of 8 kD to 40,000 kD, hydrolysed...
|
|
|
6727357 |
Liquid thickener for surfactant systems
Compositions comprising alkoxylated lipophilic polyol compounds, e.g., ehtoxylated, esterified methyl glucosides, are disclosed wherein at least 5% of the polyol derivatives have about three moles...
|
|
|
6723704 |
Sphingoglycolipid
A glycosphingolipid having a sugar chain containing α-glucosamine and β-glucosamine is disclosed. Such glycosphingolipid is advantageous in that possibly being manufactured in a facile and...
|
|
|
6723429 |
Method for preparing smooth-surface spherical microparticles completely or partially made of at least one water-insoluble linear polysaccharide and microparticles produced according to this method
The present invention relates to a method for preparing smooth-surface spherical microparticles which are completely or partially made of at least one water-insoluble linear polysaccharide. This...
|
|
|
6720418 |
Derivatized reduced malto-oligosaccharides
Disclosed are derivatized malto-oligosaccharides and methods for the preparation thereof. In accordance with the disclosed invention, a malto-oligosaccharide is hydrogenated to thereby obtain a...
|
|
|
6713624 |
Starch-based modeling compound
A starch-based modeling compound includes a starch-based binder and about 2% to about 10% retrogradation inhibitor, such as waxy corn starch.
|
|
|
6713460 |
Glass-like polysaccharide useful as absorbent for liquids
A particulate absorbent, for the absorption of liquids, comprising particles selected from the group consisting of particles of glass-like polysaccharides and of particles of glass-like...
|
|
|
RE38484 |
Cationized hydroxyalkylcellulose and process for producing the same
Cationized hydroxyalkylcelluloses, which are highly compatible with surfactants, are represented by the following formula (I): wherein R 1 , R 2 and R 3 represent a hydrogen atom or a group...
|
|
|
6710176 |
Process for producing water-soluble polysaccharides, and method for clarifying water-soluble polysaccharide aqueous solutions
By amylase treatment of water-soluble polysaccharide aqueous solutions extracted from legumes under acidic conditions, for hydrolysis of the starch substances that are a source of precipitates and...
|
|
|
6706697 |
Diabetic nutrition and weight loss drink compositions
A diabetic nutrition and weight loss drink powder composition comprising a major amount of isolated soy protein, milk protein isolate, and fructose; a minor amount of inulin, guar gum, potassium...
|
|
|
6706696 |
Cosmetic and/or pharmaceutical preparations
The invention relates to cosmetic and/or pharmaceutical preparations containing (a) water soluble β-(1,3) glucans that are substantially devoid of β-(1,6) links, and (b) deoxyribonucleic acids...
|
|
|
6703498 |
Water-soluble polymeric metal ion affinity compositions and methods for using the same
Water-soluble metal ion affinity compounds and methods for using the same are provided. The subject compounds include an aspartate based metal chelating ligand bonded to a water-soluble polymeric...
|
|
|
6699363 |
Modified starch and process therefor
A process that can be used for producing a starch product is provided. The process comprises heating a composition, which comprises or consists essentially of a starch, a polyacrylamide, and a...
|
|
|
6699848 |
Bioadhesive anti-inflammatory pharmaceutical compositions
Disclosed are compounds having the formula wherein R 2 is hydrogen, a monomeric glycoside or an oligomeric glycoside, R 3 is hydrogen, a monomeric glycoside, an oligomeric glycoside, or a...
|
|
|
6699845 |
Excipient
An excipient comprising trehalose having a purity of 99.0% or more, a proportion of particles of 75 μm or more of 2 to 90 wt %, an average particle size of 10 to 250 μm, an apparent specific...
|
|
|
6696563 |
α-Amylase-resistant polysaccharides, production method, use and foods containing these polysaccharides
The invention relates to a production method of α-amylase resistant polysaccharides with high RS content, comprising the following steps: a) producing a paste of water-insoluble...
|
|
|
6693180 |
Composite sponge wound dressing made of β-Chitin and Chitosan and method for producing the same
The present invention relates to a composite sponge wound dressing and method for producing the same. Chitosan and β-Chitin is mixed in a specific ratio for forming the sponge for wound repairing....
|
|
|
6689764 |
Treatment of angiogenesis dependent conditions with dextrin sulphate
The invention relates to the inhibitory effects of dextrin sulphate on angiogenesis and in particular the treatment of diseases or disorders which would benefit from the administration of dextrin...
|
|
|
6686457 |
Material
Material characterized by that the material contains at least one biologically active saccharide which is covalently bound via at least one spacer to a crosslinked matrix.
|
|
|
6686341 |
Nutritional compositions which contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions
A nutritional composition which contains slightly negatively charged non-digestible polysaccharides having a molecular weight of 8 kD to 40,000 kD, characterized in that the rise in the viscosity...
|
|
|
6680306 |
Method for enhancing the effectiveness of cancer therapies
The efficacy of conventional cancer therapies such as surgery, chemotherapy and radiation is enhanced by the use of a therapeutic material which binds to and interacts with galectins. The...
|
|
|
6677446 |
Cross-linked polymers based on bis-silane, bis-thioether, bis-sulphoxide, bis-sulphone and butane-di-yl derivatives of polysaccharides an oligosaccharides, and their shaping as support materials
There are described novel cross-linked polymers based on bis-silane, bis-thioether, bis-sulphoxide, bis-sulphone and butane-di-yl derivatives of polysaccharides and oligosaccharides, their shaping...
|
|
|
6677318 |
Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
The invention relates to an orally administerted agent containing stable, uronic acid-containing polysaccharides cross-linked to each other and in the form of a sponge-like structure which...
|
|
|
6670338 |
Pentasaccharides processes for their preparation and pharmaceutical compositions containing them
Pentasaccharides in acidic form and their pharmaceutically acceptable salts, the anionic form thereof having the formula: wherein: R represents hydrogen or an —SO 3 − , (C 1 -C 3 )alkyl or...
|
|
|
6667296 |
Method for preventing and reducing radiation cystitis using hyaluronic acid
A method for preventing, reducing or treating radiation cystitis caused by external beam radiation therapy, which impinges on the urinary bladder and associated structures, comprising administering...
|
|
|
6667396 |
Polyxyloside derivatives, process for preparing them, composition containing them and use as surfactants
Novel compounds of formula (I): RO—(X) p (I) in which p represents a decimal number between 1 and 5, x represents a xylose residue, and R represents a radical: CH(C n H 2n+1 )(C m H 2m+1...
|
|
|
6663886 |
Inhibition of cell-cell binding by lipid assemblies
This invention relates generally to the field of therapeutic compounds designed to interfere between the binding of ligands and their receptors on cell surface. More specifically, it provides...
|
|
|
6660853 |
Method for purifying high molecular weight hyaluronic acid
A method for purifying high molecular weight hyaluronic acid, comprising the steps of providing one or more raw hyaluronic acid sources; extracting hyaluronic acid from the source; precipitating...
|
|
|
6660722 |
Therapeutical treatments
Therapeutical method comprising administration to a patient of an effective amount of especially soluble laminarin for the treatment of tumors and more generally of cancers of the group comprising...
|
|
|
6656924 |
Immunopotentiating compositions
The invention provides an immunopotentiating composition and to a composition accelerating the production of interferon-γ, both comprising lactosuclose as an active ingredient. In particular, the...
|
|
|
6656922 |
Oral delivery of macromolecules
Polysaccharides, which are widely used as an anticoagulation drugs, especially heparin, are clinically administered only by intravenous or subcutaneous injection because of their strong...
|
|
|
6653457 |
Method of covalent coupling
A method of preparing conjugates by means of covalent coupling of a polysaccharide selected from heparin, heparin derivatives, at least partially deacerylated dermatan sulphate and dextran sulphate...
|
|
|
6649591 |
Polydithicarbamate-containing non-targeting marcomolecules and the use thereof for therapeutic and diagnostic applications
In accordance with the present invention, there is provided a new class of drugs for therapeutic treatment of such indications as cerebral stroke and other ischemia/reperfusion injury. Thus, in...
|
|
|
6645503 |
Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria
Antigenic conjugates are provided which comprise a carrier protein covalently bonded to the conserved portion of a lipopolysaccharide of a gram negative bacteria, wherein the conserved portion of...
|
|
|
6642205 |
Methods and compositions for reducing side effects in chemotherapeutic treatments
A pharmaceutical compound and a process for making the compound is provided where the compound includes a therapeutic agent, a spacer and a galactose, the spacer being covalently linked to the...
|
|
|
6638513 |
Neisseria meningitidis serogroup B Glycoconjugates
The present invention pertains generally to Neisseria meningitidis serogroup B glycoconjugates. More particularly, the invention pertains to glycoconjugates formed from a Neisseria meningitidis ...
|
|
|
6638918 |
Chitosan compositions
Compositions comprising chitosan in the form of a network of nano-sized fibres. There is also provided a process for making such compositions. The compositions have improved solubility and...
|